206 related articles for article (PubMed ID: 25347075)
1. A machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.gov.
de la Iglesia D; García-Remesal M; Anguita A; Muñoz-Mármol M; Kulikowski C; Maojo V
PLoS One; 2014; 9(10):e110331. PubMed ID: 25347075
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
5. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
7. Analysis of inequality in nanomedicine using clinical trials and disease burden.
Woodson T; Rodriguez V
Nanomedicine (Lond); 2019 Jul; 14(13):1745-1757. PubMed ID: 31298067
[No Abstract] [Full Text] [Related]
8. Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
Satalkar P; Elger BS; Shaw DM
Sci Eng Ethics; 2016 Oct; 22(5):1255-1276. PubMed ID: 26373718
[TBL] [Abstract][Full Text] [Related]
9. Nanoinformatics: new challenges for biomedical informatics at the nano level.
De La Iglesia D; Chiesa S; Kern J; Maojo V; Martin-Sanchez F; Potamias G; Moustakis V; Mitchell JA
Stud Health Technol Inform; 2009; 150():987-91. PubMed ID: 19745461
[TBL] [Abstract][Full Text] [Related]
10. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Nano-Bio Interfaces.
Cai P; Zhang X; Wang M; Wu YL; Chen X
ACS Nano; 2018 Jun; 12(6):5078-5084. PubMed ID: 29883094
[TBL] [Abstract][Full Text] [Related]
13. Results publications are inadequately linked to trial registrations: An automated pipeline and evaluation of German university medical centers.
Salholz-Hillel M; Strech D; Carlisle BG
Clin Trials; 2022 Jun; 19(3):337-346. PubMed ID: 35362331
[TBL] [Abstract][Full Text] [Related]
14. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields.
Schindler TM; Grieger F; Zak A; Rorig R; Chowdary Konka K; Ellsworth A; Pfitzer C; Hodge K; Crandall C;
PLoS One; 2020; 15(5):e0233294. PubMed ID: 32469901
[TBL] [Abstract][Full Text] [Related]
16. Nanodrugs used in cancer therapy.
Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Automatic detection and classification of treatment deviations in proton therapy from realistically simulated prompt gamma imaging data.
Pietsch J; Khamfongkhruea C; Berthold J; Janssens G; Stützer K; Löck S; Richter C
Med Phys; 2023 Jan; 50(1):506-517. PubMed ID: 36102783
[TBL] [Abstract][Full Text] [Related]
19. [Nanopsychiatry. The potential role of nanotechnologies in the future of psychiatry. A systematic review].
Fond G; Miot S
Encephale; 2013 Sep; 39(4):252-7. PubMed ID: 23545476
[TBL] [Abstract][Full Text] [Related]
20. Using natural language processing techniques to inform research on nanotechnology.
Lewinski NA; McInnes BT
Beilstein J Nanotechnol; 2015; 6():1439-49. PubMed ID: 26199848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
